Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1.
Vpr, an accessory gene of HIV-1, induces cell cycle abnormality with accumulation at G2/M phase and increased ploidy. Since abnormality of mitotic checkpoint control provides a molecular basis of genomic instability, we studied the effects of Vpr on genetic integrity using a stable clone, named MIT-23, in which Vpr expression is controlled by the tetracycline-responsive promoter. Treatment of MIT-23 cells with doxycycline (DOX) induced Vpr expression with a giant multinuclear cell formation. Increased micronuclei (MIN) formation was also detected in these cells. Abolishment of Vpr expression by DOX removal induced numerous asynchronous cytokinesis in the multinuclear cells with leaving MIN in cytoplasm, suggesting that the transient Vpr expression could cause genetic unbalance. Consistent with this expectation, MIT-23 cells, originally pseudodiploid cells, became aneuploid after repeated expression of Vpr. Experiments using deletion mutants of Vpr revealed that the domain inducing MIN formation as well as multinucleation was located in the carboxy-terminal region of Vpr protein. These results suggest that Vpr induces genomic instability, implicating the possible role in the development of AIDS-related malignancies.
Shimura
M
M
Department of Intractable Diseases, International Medical Center of Japan, Shinjuku-ku, Tokyo.
Tanaka
Y
Y
Nakamura
S
S
Minemoto
Y
Y
Yamashita
K
K
Hatake
K
K
Takaku
F
F
Ishizaka
Y
Y
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000595:Amino Acid Sequence; D000782:Aneuploidy; D002453:Cell Cycle / Q000502:physiology; D016336:Gene Products, vpr / Q000096:biosynthesis / Q000235:genetics; D016334:Genes, vpr; D015726:Giant Cells; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000209:etiology; D048629:Micronuclei, Chromosome-Defective; D008969:Molecular Sequence Data; D011994:Recombinant Proteins / Q000096:biosynthesis; D012514:Sarcoma, Kaposi / Q000209:etiology; D054325:vpr Gene Products, Human Immunodeficiency Virus
D016336:Gene Products, vpr; D011994:Recombinant Proteins; D054325:vpr Gene Products, Human Immunodeficiency Virus